REQUEST A DEMO
Total
USD $0.00
Search more companies

Comercializadora de Medicamentos Bacata S A S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Comercializadora de Medicamentos Bacata S A S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Comercializadora de Medicamentos Bacata S A S is an enterprise in Colombia, with the main office in Bogota D.C.. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on July 29, 2013. It currently has a total number of 10 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 23.34% in 2023. A growth of 27.57% was recorded in its total assets. The net profit margin of Comercializadora de Medicamentos Bacata S A S increased by 0.46% in 2023.

Headquarters
Cra 74B 52A 05
Bogota D.C.; Bogota D.C; Postal Code: 0910

Contact Details: Purchase the Comercializadora de Medicamentos Bacata S A S report to view the information.

Basic Information
Total Employees:
Purchase the Comercializadora de Medicamentos Bacata S A S report to view the information.
Outstanding Shares:
Purchase the Comercializadora de Medicamentos Bacata S A S report to view the information.
Incorporation Date:
July 29, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Comercializadora de Medicamentos Bacata S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
23.34%
Total operating revenue
23.34%
Operating profit (EBIT)
45.76%
Net Profit (Loss) for the Period
54.04%
Total assets
27.57%
Total equity
16.01%
Operating Profit Margin (ROS)
0.56%
Net Profit Margin
0.46%
Return on Equity (ROE)
3.4%
Quick Ratio
-0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?